Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOUNDS USEFUL AS IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: COMBINATION THERAPY WITH ANTI-IL-8 ANTIBODIES AND ANTI-PD-1 ANTIBODIES FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR Filling date: 6 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS OF TREATING TUMOR Filling date: 6 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: HETEROCYCLIC COMPOUNDS COMPRISING PYRIDINE USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Filling date: 6 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING CANCER Filling date: 6 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: REAL-TIME MONITORING OF PROTEIN CONCENTRATION USING ULTRAVIOLET SIGNAL Filling date: 6 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: METHOD OF PURITY DETERMINATION BY CAPILLARY ELECTROPHORESIS Filling date: 6 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: ANTI-GITR ANTIBODIES FOR CANCER DIAGNOSTICS Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METHODS OF PURIFYING MONOMERIC MONOCLONAL ANTIBODIES Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METABOLIC ENZYME ACTIVITY AND DISULFIDE BOND REDUCTION DURING PROTEIN PRODUCTION Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS Filling date: 6 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-1 ANTIBODY TO TREAT TUMORS Filling date: 6 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: ANTIBODIES AGAINST OX-40 AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: ISOFURANONE COMPOUNDS USEFUL AS HPK1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: 6-AZAINDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: BSL2v2c2-Ig POLYPEPTIDES Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: [1,2,4]TRIAZOLO[4,3-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: SUBSTITUTED NITROGEN CONTAINING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: AMINO INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: AMIDE SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR Filling date: 6 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: BIARYL KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A HETEROBIARYL MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: CYCLOHEXYL ACID ISOXAZOLE AZOLES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: CYCLOHEXYL ACID ISOXAZOLE AZINES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: ISOXAZOLE O-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A PYRIDINE OR PYRAZINE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: DIAZAINDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: ISOXAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: PYRAZOLE O-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: PYRROLIDINE GPR40 MODULATORS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: A METHOD TO MONITOR PHARMACODYNAMIC RESPONSES MEDIATED BY IN VIVO ADMINISTRATION OF GLUCOCORTICOIDS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Showing 200 to 250 of 438 patents.